Terms: = Leukemia AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45
1079 results:
1. Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid leukemia and Overcoming Resistance of FLT3 Inhibitors.
Wang J; Rong Q; Ye L; Fang B; Zhao Y; Sun Y; Zhou H; Wang D; He J; Cui Z; Zhang Q; Kang D; Hu L
J Med Chem; 2024 May; 67(9):7197-7223. PubMed ID: 38655686
[TBL] [Abstract] [Full Text] [Related]
2. Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells.
Suzuki S; Liu J; Sato Y; Miyake R; Suzuki S; Okitsu Y; Fukuda T; Isaji T; Gu J; Takahashi S
Biochem Biophys Res Commun; 2024 May; 710():149541. PubMed ID: 38608490
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
Zhu G; Lang W; Fu W; Xu L; Cai J; Zhong H
Int Immunopharmacol; 2024 May; 132():111927. PubMed ID: 38555820
[TBL] [Abstract] [Full Text] [Related]
4. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
[TBL] [Abstract] [Full Text] [Related]
5. Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood.
De Stefano A; Cappellini A; Casalin I; Paolini S; Parisi S; Marvi MV; Fazio A; Neri I; Koufi FD; Ratti S; Finelli C; Curti A; Manzoli L; Cocco L; Follo MY
Methods Mol Biol; 2024; 2777():163-176. PubMed ID: 38478343
[TBL] [Abstract] [Full Text] [Related]
6. The immutable relevance of myeloid sarcomas: Clinicopathological study of fourteen cases.
Lizardo-Thiebaud Maria J; Emilio AH; Jesus DM; Montante-Montes de Oca D
Pathol Res Pract; 2024 Mar; 255():155176. PubMed ID: 38394809
[TBL] [Abstract] [Full Text] [Related]
7. The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia.
Prelog T; Bucek S; Brozic A; Peterlin J; Kavcic M; Omerzel M; Markelc B; Jesenko T; Prevodnik VK
Radiol Oncol; 2024 Mar; 58(1):133-144. PubMed ID: 38378030
[TBL] [Abstract] [Full Text] [Related]
8. Licochalcone A induces mitochondria-dependent apoptosis and interacts with venetoclax in acute myeloid leukemia.
Li Y; Zhao M; Lin Y; Jiang X; Jin L; Ye P; Lu Y; Pei R; Jiang L
Eur J Pharmacol; 2024 Apr; 968():176418. PubMed ID: 38350590
[TBL] [Abstract] [Full Text] [Related]
9. Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data.
Gross Z; Veyrat-Masson R; Grange B; Huet S; Verney A; Traverse-Glehen A; Ruminy P; Baseggio L
Hematol Oncol; 2024 Jan; 42(1):e3245. PubMed ID: 38287532
[TBL] [Abstract] [Full Text] [Related]
10. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
[TBL] [Abstract] [Full Text] [Related]
11. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
[TBL] [Abstract] [Full Text] [Related]
12. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract] [Full Text] [Related]
14. Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.
Vogt M; Dienstbier N; Schliehe-Diecks J; Scharov K; Tu JW; Gebing P; Hogenkamp J; Bilen BS; Furlan S; Picard D; Remke M; Yasin L; Bickel D; Kalia M; Iacoangeli A; Lenz T; Stühler K; Pandyra AA; Hauer J; Fischer U; Wagener R; Borkhardt A; Bhatia S
Cell Death Dis; 2023 Dec; 14(12):799. PubMed ID: 38057328
[TBL] [Abstract] [Full Text] [Related]
15. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
16. Targeted Radiation Delivery before Haploidentical HCT for High-risk leukemia or MDS Patients Yields Long-term Survivors.
Orozco JJ; Vo PT; Gooley TA; Haaf RL; Lundberg SJ; Hamlin DK; Wilbur DS; Matesan MC; Fisher DR; Gopal AK; Green DJ; Pagel JM; Sandmaier BM
Clin Cancer Res; 2024 Jan; 30(2):274-282. PubMed ID: 37939122
[TBL] [Abstract] [Full Text] [Related]
17. Long-Term Stability of Cord Blood Units After 29 Years of Cryopreservation: Follow-Up Data From the José Carreras Cord Blood Bank.
Liedtke S; Többen S; Gressmann H; Meyer A; Verde PE; Gluckman E; Kogler G
Stem Cells Transl Med; 2024 Jan; 13(1):30-42. PubMed ID: 37936262
[TBL] [Abstract] [Full Text] [Related]
18. cd45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy.
Al Barashdi MAS; Ali A; McMullin MF; Mills K
Ann Hematol; 2024 Jan; 103(1):73-88. PubMed ID: 37917373
[TBL] [Abstract] [Full Text] [Related]
19. [Role of Flow Cytometry in the Diagnosis of Chronic Myeloid leukemia].
Huang W; Liu RR; Wu YY; Li SS; Tang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1327-1332. PubMed ID: 37846680
[TBL] [Abstract] [Full Text] [Related]
20. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
[TBL] [Abstract] [Full Text] [Related]
[Next]